Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Our history
Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation.
Remote effects of intermittent theta burst stimulation of the human pharyngeal motor system.
About Tysabri
The Role of Demyelination in Neuromyelitis Optica Damage: Diffusion-Tensor MR Imaging Study.
Homophilic interaction of the L1 family of cell adhesion molecules.
Sativex(®) in multiple sclerosis spasticity: a cost-effectiveness model.
The use of aminopyridines in neurological disorders.
T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial.
Please mind the gap: axonal transport deficits in multiple sclerosis neurodegeneration.
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.
Laquinimod delays and suppresses nephritis in lupus-prone mice and affects both myeloid and lymphoid immune cells.
Multiple sclerosis.
The genetics of multiple sclerosis.
Genome-wide pathway analysis of a genome-wide association study on multiple sclerosis.
Efficient transdifferentiation of human adipose-derived stem cells into Schwann-like cells: A promise for treatment of demyelinating diseases.
Paroxysmal Hypothermia in Two Patients with Multiple Sclerosis.
Sarcoidosis and multiple sclerosis: systemic toxicity associated with the use of interferon-beta therapy.
Using a highly abbreviated California Verbal Learning Test-II to detect verbal memory deficits.
HyperCKemia Related to the Initial and Recurrent Attacks of Neuromyelitis Optica.
Targeting S1P receptors in experimental autoimmune encephalomyelitis in mice improves early deficits in locomotor activity and increases ultrasonic vocalisations.
Cumulative review of thrombotic microangiopathy, thrombotic thrombocytopenic purpura and hemolytic uremic syndrome reports with SC interferon beta-1a.
High-dose cyclophosphamide in the treatment of multiple sclerosis.
Modeling the heterogeneity of multiple sclerosis in animals.
Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease.

Pages